Cargando…

Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN

BACKGROUND: Inhibitor of differentiation 4 (Id4), a member of the helix-loop-helix family of transcriptional regulators has emerged as a tumor suppressor in prostate cancer. Id4 is expressed in the normal prostate where its expression is also regulated by androgens. In this study we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Pankaj, Knowell, Ashley Evans, Chinaranagari, Swathi, Komaragiri, Shravan, Nagappan, Peri, Patel, Divya, Havrda, Mathew C, Chaudhary, Jaideep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694449/ https://www.ncbi.nlm.nih.gov/pubmed/23786676 http://dx.doi.org/10.1186/1476-4598-12-67

Ejemplares similares

Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer
por: Sharma, Pankaj, et al.
Publicado: (2012)

EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer
por: Chinaranagari, Swathi, et al.
Publicado: (2014)

Id4 dependent acetylation restores mutant-p53 transcriptional activity
por: Knowell, Ashley E, et al.
Publicado: (2013)

Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52
por: Joshi, Jugal Bharat, et al.
Publicado: (2017)

Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
por: Sharma, Pankaj, et al.
Publicado: (2012)

ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation
por: Morton, Derrick J, et al.
Publicado: (2016)

The helix-loop-helix transcriptional regulator Id4 is required for terminal differentiation of luminal epithelial cells in the prostate
por: Hewa Bostanthirige, Dhanushka, et al.
Publicado: (2021)

Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth
por: Korang-Yeboah, Maxwell, et al.
Publicado: (2016)

Concurrent Down-Regulation of PTEN and NKX3.1 Expression in Iranian Patients with Prostate Cancer
por: Nodouzi, Vahideh, et al.
Publicado: (2015)

The Role of Nkx3.1 in Cancers and Stemness
por: Antao, Ainsley Mike, et al.
Publicado: (2021)

Nkx3.1 controls the DNA repair response in the mouse prostate
por: Zhang, Hailan, et al.
Publicado: (2015)

Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation
por: Le Magnen, Clémentine, et al.
Publicado: (2018)

Inhibitor of differentiation 1 (Id1) promotes cell survival and proliferation of prostate epithelial cells
por: Schmidt, Michelle, et al.
Publicado: (2010)

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation
por: Lind, Guro E, et al.
Publicado: (2005)

Antioxidant Treatment Promotes Prostate Epithelial Proliferation in Nkx3.1 Mutant Mice
por: Martinez, Erin E., et al.
Publicado: (2012)

miR-378b Promotes Differentiation of Keratinocytes through NKX3.1
por: Wang, Xi-liang, et al.
Publicado: (2015)

LIMK2-NKX3.1 Engagement Promotes Castration-Resistant Prostate Cancer
por: Sooreshjani, Moloud A., et al.
Publicado: (2021)

NKX3.1 Expression Contributes to Epithelial–Mesenchymal Transition of Prostate Cancer Cells
por: Saydullaeva, Iroda, et al.
Publicado: (2023)

Behavioral abnormalities and Parkinson’s-like histological changes resulting from Id2 inactivation in mice
por: Havrda, Matthew C., et al.
Publicado: (2013)

ID2 promotes survival of glioblastoma cells during metabolic stress by regulating mitochondrial function
por: Zhang, Zhonghua, et al.
Publicado: (2017)

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer
por: Carey, Jason PW, et al.
Publicado: (2009)

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
por: Kristiansen, Ilka, et al.
Publicado: (2017)

Loss-of-Nkx3.1 Leads to Activation of Discrete Downstream Target Genes during Prostate Tumorigenesis
por: Song, Haengseok, et al.
Publicado: (2009)

The Homeodomain Transcription Factor NKX3.1 Modulates Bladder Outlet Obstruction Induced Fibrosis in Mice
por: Patel, Mehul S., et al.
Publicado: (2019)

Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models
por: Sooreshjani, Moloud Aflaki, et al.
Publicado: (2021)

MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells
por: Iwata, Tsuyoshi, et al.
Publicado: (2010)

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014)

TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells
por: Eide, Turid, et al.
Publicado: (2013)

Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation
por: Yang, Chih-Cheng, et al.
Publicado: (2014)

Expression of NKX3.1, Prostatic Specific Antigen and Prostatic Specific Alkaline Phosphatase in Cytology Specimens of Metastatic Prostatic Carcinoma
por: Wang, Minhua, et al.
Publicado: (2021)

Nkx2.7 and Nkx2.5 Function Redundantly and Are Required for Cardiac Morphogenesis of Zebrafish Embryos
por: Tu, Chi-Tang, et al.
Publicado: (2009)

ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
por: Kunderfranco, Paolo, et al.
Publicado: (2010)

Deletion of NKX3.1 via CRISPR/Cas9 Induces Prostatic Intraepithelial Neoplasia in C57BL/6 Mice
por: Park, Jin Ju, et al.
Publicado: (2020)

The NANCI–Nkx2.1 gene duplex buffers Nkx2.1 expression to maintain lung development and homeostasis
por: Herriges, Michael J., et al.
Publicado: (2017)

NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML
por: Nagel, Stefan, et al.
Publicado: (2021)

Genetic Interaction between Tmprss2-ERG Gene Fusion and Nkx3.1-Loss Does Not Enhance Prostate Tumorigenesis in Mouse Models
por: Linn, Douglas E., et al.
Publicado: (2015)

Expression of Sumoylation Deficient Nkx2.5 Mutant in Nkx2.5 Haploinsufficient Mice Leads to Congenital Heart Defects
por: Kim, Eun Young, et al.
Publicado: (2011)

Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor
por: Leung, Jacky K., et al.
Publicado: (2021)

Characterization of two functional NKX3.1 binding sites upstream of the PCAN1 gene that are involved in the positive regulation of PCAN1 gene transcription
por: Liu, Wenwen, et al.
Publicado: (2008)

NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia
por: Kusy, Sophie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_oihbn4eaig843p7mqu2qdcava1